» Articles » PMID: 37484805

Low Expression of GIGYF1 Inhibits Metastasis, Proliferation, and Promotes Apoptosis and Autophagy of Gastric Cancer Cells

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2023 Jul 24
PMID 37484805
Authors
Affiliations
Soon will be listed here.
Abstract

GRB10 interacting GYF protein 1 (GIGYF1) binds to the N-terminal region of Grb10, regulates multiple signaling pathways. However, it is not clear what happens to cell proliferation, metastasis, apoptosis, and autophagy when the expression level of GIGYF1 gene is reduced. Detection of GIGYF1 expression in clinical tissue specimens and gastric cancer (GC) cell lines by quantitative Real-time PCR (qRT-PCR), GIGYF1 gene was knocked down in MGC-803 cells using small interfering RNA, the effect of GIGYF1 gene on cell metastasis was detected using Transwell assay and wound healing assay, the effect on cell proliferation was detected using plate cloning assay and cck-8 assay, the effect on apoptosis was detected using flow cytometry, autophagosomes were detected using laser confocal microscopy, and the effect on protein expression was detected using immunofluorescence and Western blotting. GIGYF1 gene expression was higher in tumor tissue samples than in paracancer tissue samples, and higher in human GC cell lines than in human normal gastric epithelial cells. GIGYF1 gene knockdown inhibited cell migration, scratch healing ability and EMT process, weakened cell proliferation ability, increased apoptosis rate, promoted the formation of autophagosomes, and changed the corresponding protein expression level. Meanwhile, GIGYF1 knockdowns inhibited the ERK and AKT signaling. In conclusion, the low expression of GIGYF1 gene can inhibit the occurrence and progression of gastric cancer, during which the ERK and AKT signaling pathways are inhibited.

Citing Articles

Identify characteristics of Vietnamese oral squamous cell carcinoma patients by machine learning on transcriptome and clinical-histopathological analysis.

Duong H, Huynh N, Nguyen C, Le L, Nguyen K, Nguyen H J Dent Sci. 2025; 19(Suppl 1):S81-S90.

PMID: 39807441 PMC: 11725156. DOI: 10.1016/j.jds.2024.08.013.


Evaluation of a three-gene methylation model for correlating lymph node metastasis in postoperative early gastric cancer adjacent samples.

Chen S, Long S, Liu Y, Wang S, Hu Q, Fu L Front Oncol. 2024; 14:1432869.

PMID: 39484038 PMC: 11524798. DOI: 10.3389/fonc.2024.1432869.


High expression of ABL2 promotes gastric cancer cells migration, invasion and proliferation via the TGF-β and YAP signaling pathways.

Liu Y, Jin T, Chen R, Miao R, Zhou Y, Shao S J Cancer. 2024; 15(17):5719-5728.

PMID: 39308677 PMC: 11414612. DOI: 10.7150/jca.99307.


Comprehensive DNA methylation profiling by MeDIP-NGS identifies potential genes and pathways for epithelial ovarian cancer.

Gautam P, Gupta S, Sachan M J Ovarian Res. 2024; 17(1):83.

PMID: 38627856 PMC: 11022481. DOI: 10.1186/s13048-024-01395-3.

References
1.
Ruscica V, Bawankar P, Peter D, Helms S, Igreja C, Izaurralde E . Direct role for the Drosophila GIGYF protein in 4EHP-mediated mRNA repression. Nucleic Acids Res. 2019; 47(13):7035-7048. PMC: 6648886. DOI: 10.1093/nar/gkz429. View

2.
Liu Y, Cao J, Zhu L, Zhao W, Zhou Y, Shao C . Circular RNA circPGD contributes to gastric cancer progression via the sponging miR-16-5p/ABL2 axis and encodes a novel PGD-219aa protein. Cell Death Discov. 2022; 8(1):384. PMC: 9472197. DOI: 10.1038/s41420-022-01177-0. View

3.
Huang C, Liu H, Hu Y, Sun Y, Su X, Cao H . Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial. JAMA Surg. 2021; 157(1):9-17. PMC: 8529527. DOI: 10.1001/jamasurg.2021.5104. View

4.
Lei Z, Teng Q, Tian Q, Chen W, Xie Y, Wu K . Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduct Target Ther. 2022; 7(1):358. PMC: 9547882. DOI: 10.1038/s41392-022-01190-w. View

5.
Curtis D . Analysis of rare coding variants in 200,000 exome-sequenced subjects reveals novel genetic risk factors for type 2 diabetes. Diabetes Metab Res Rev. 2021; 38(1):e3482. DOI: 10.1002/dmrr.3482. View